Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.
Frequently asked questions
What sector does Seegene Inc (096530) operate in?
Seegene Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Seegene Inc (096530) current stock price?
As of the latest data, Seegene Inc stock price is ₩31,900, with a previous close of ₩31,950. Seegene Inc lost -₩50 in the last trading session, representing a -0.16% loss.
What is Seegene Inc (096530) current market capitalization?
Seegene Inc market cap is approximately 1.45 trillion.
Does Seegene Inc (096530) pay dividends?
Yes. Seegene Inc pays quarterly dividends with an annualized yield of 2.51% and an estimated annual payout of ₩800 per share.
When is the next ex-dividend date for Seegene Inc (096530)?
The next ex-dividend date is scheduled for September 29, 2026.
When is Seegene Inc (096530) next earnings report?
Seegene Inc is expected to release its next earnings report on June 30, 2026.
What is Seegene Inc (096530) beta (volatility) score?
Seegene Inc has a beta of 0.875, meaning its volatility is roughly in line with the market.
